Litcius/Paper detail

First approval of a complement C3 inhibitor opens up autoimmune and inflammatory opportunities

Asher Mullard

2021Nature Reviews Drug Discovery19 citationsDOI

Topics & Concepts

Complement (music)Drug approvalMedicineImmunologyComplement systemPharmacologyAntibodyDrugBiologyGeneticsGenePhenotypeComplementationComplement system in diseasesCoagulation, Bradykinin, Polyphosphates, and AngioedemaPhagocytosis and Immune Regulation
First approval of a complement C3 inhibitor opens up autoimmune and inflammatory opportunities | Litcius